Study Group: Council Members in the U.S. who are Familiar with Regulations Pertaining to Andrx Corporation's Form 483

Council Members in this Study Group: 19

This study group may include physicians, care providers, and researchers specializing in internal medicine, cardiology, oncology, dermatology, emergency medicine, family medicine, neurology, obstetrics-gynecology, psychiatry, radiology, nursing, optometry, genetics, and mental health. It may also include experts knowledgeable on diagnostic labs, disease management, medical devices, long term care, surgery centers, health management, pharma, and biotechnology, among others.

Contact Gerson Lehrman Group to survey or consult with members of this Study Group

Leading institutions connect with members of this Study Group through GLG

Leading Experts in this Study Group

Evan Siegel

Adjunct Professor
THE UNIVERSITY OF QUEENSLAND
What is a GLG Leader?|The Gerson Lehrman Group&reg; (GLG) Leader Program<sup>SM</sup> is our premium Member Program<sup>SM</sup>. Those identified as GLG Leaders are in the top 5% of GLG CouncilRank and have an exclusivity agreement with GLG.

Evan Siegel, M Phil, Ph D, is the President and Chief Executive Officer of Ground Zero Pharmaceuticals, a regulatory affairs and product development consulting firm in California, since June 1999. Dr. Siegel is also an Adjunct Professor at the University...

8 news post(s)
1 event(s)
Jim Farley, President, Cardinal Consulting and TrainingJim Farley

President
Cardinal Consulting and Training
What is a GLG Leader?|The Gerson Lehrman Group&reg; (GLG) Leader Program<sup>SM</sup> is our premium Member Program<sup>SM</sup>. Those identified as GLG Leaders are in the top 5% of GLG CouncilRank and have an exclusivity agreement with GLG.

Jim Farley is an Independent Consultant and Owner of Cardinal Consulting and Training. Formerly, Mr. Farley served as the Director of the Science Branch of Philadelphia District FDA. He has over 30 years of experience in pharmaceutical and pharmaceutical...

2 news post(s)
Marc Scheineson, Partner & Chair, Food and Drug Practice, ALSTON & BIRD LLPMarc Scheineson

Partner & Chair, Food and Drug Practice
ALSTON & BIRD LLP
What is a GLG Leader?|The Gerson Lehrman Group&reg; (GLG) Leader Program<sup>SM</sup> is our premium Member Program<sup>SM</sup>. Those identified as GLG Leaders are in the top 5% of GLG CouncilRank and have an exclusivity agreement with GLG.

Marc Scheineson is a Partner with Alston & Bird where he heads the firm's Food and Drug Law Practice. He has practiced food and drug law, health care law, and administrative law for over 20 years in national law firms and at the FDA. His practice focuses...

Join this Study Group

Members in this Study Group include these company types:

  • Law Firm (general practice/large)
  • Consultancy, Pharma-Focused
  • Pharmaceuticals Manufacturer
  • Individual/Small Consultancy
  • Academic Institution*
  • Consultancy, Healthcare-Focused
  • Biotechnology Manufacturer
  • Consulting Firm
  • Policy or Political Consulting Firm
  • Pharmaceuticals/Biotechnology Research Services

Members in this Study Group often have these job titles:

  • Principal
  • Partner
  • President
  • Director
  • Consultant
  • Engineer
  • Professor

Related Study Groups

Study Group Name No. Members
Biotechnology Patent Experts: Lawyers (US) 98
Medical Device Experts 513
Charles River Labs Toxicology Services Users 13
Nanotechnology Materials Experts 37
Economic Experts: Pharmaceutical Contract Manufacturing and Analytical Services (US) 22
Nanotechnology Material Experts (North America) 29
QT Interval Prolongation Experts (US) 64
FDA Medical Device Regulations Experts: Legal, Economic, and Regulatory Affairs 51

GLG Live Meetings with this Study Group's Leading Experts (?)

October 26, 2006 | Palo Alto

GLGi: New Drug Application Process

GLG Webcasts & Teleconferences

Leading Experts in Council Members in the U.S. who are Familiar with Regulations Pertaining to Andrx Corporation's Form 483 have not participated in any GLG webcasts.

View All GLG Webcasts & Teleconferences in Healthcare